FDA inspections find many biopharma firms struggling with CFR 21 Part 211. Learn how Merit tackles these challenges, ensuring proper procedures and documented incident management.
The post Lessons from 483 Inspections: CFR 21 Part 211 appeared first on ​Life Science ERP Software and Consulting Services for Pharma, Biotech and Medical Device.
*This post is locked for comments